The new gene therapy for childhood blindness has gone into wider use, reports Stat News. It follows the case of 13-year-old Jack Hogan, who has retinal dystrophy and who received the treatment in one eye on Tuesday.
...and receive Daily News bulletins.
Already have an account?Login Now.
The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.
A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.
The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."
In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.